VISCOFAN FIBERCOLL-FLEX Trademark

Trademark Overview


On Thursday, July 28, 2022, a trademark application was filed for VISCOFAN FIBERCOLL-FLEX with the United States Patent and Trademark Office. The USPTO has given the VISCOFAN FIBERCOLL-FLEX trademark a serial number of 79353016. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 25, 2024. This trademark is owned by VISCOFAN, S.A.. The VISCOFAN FIBERCOLL-FLEX trademark is filed in the Chemical Products, Paint Products, and Pharmaceutical Products categories with the following description:

Hydrogels for medical, veterinary and pharmaceutical purposes for cellular biology applications; hydrogels for cell growth, cell growth and transplantation, assays based on cells, cancer cell research, regenerative medicine, stem cell growth and drug delivery for medical use; hydrogels for cell culture for medical, veterinary and pharmaceutical purposes; hydrogels for cell growth for medical, veterinary and pharmaceutical purposes; cell culture media for medical use; nutritional agents for processing living cells, namely, cell culture media growth factors contained within a reservoir; synthetic peptides for the treatment of degenerated hard and soft tissues; synthetic peptide derivativesfor the treatment of degenerated hard and soft tissues; cells for medical, veterinary and pharmaceutical use; cells or tissues in hydrogels for medical, veterinary or pharmaceutical use; pharmaceutical preparations for use in 3D bio-printing of tissues and organs; pharmaceutical preparations with other ...

Inks of biological origin for printers; inks of biological origin for 3D printers

Biological materials or preparations for 3D printers, namely, bioinks, bioprinting kits comprised of collagen, biological printed tissues other than for medical or veterinary purposes; hydrogels for cell culture not for medical or veterinary purposes; hydrogels for cell growth not for medical or veterinary purposes; cell culture media other than for medical or veterinary use; nutritional agents for processing living cells other than for medical use, namely, cell culture media within a reservoir for growth factors; culture media for microbiology for laboratory use; reagents for scientific and medical research; synthetic peptides not for pharmaceutical purposes, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; synthetic peptide derivatives not for pharmaceutical purposes, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; cells other than for medical, veterinary or pharmaceutic...
viscofan fibercoll-flex

General Information


Serial Number79353016
Word MarkVISCOFAN FIBERCOLL-FLEX
Filing DateThursday, July 28, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, June 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2024

Trademark Statements


Goods and ServicesHydrogels for medical, veterinary and pharmaceutical purposes for cellular biology applications; hydrogels for cell growth, cell growth and transplantation, assays based on cells, cancer cell research, regenerative medicine, stem cell growth and drug delivery for medical use; hydrogels for cell culture for medical, veterinary and pharmaceutical purposes; hydrogels for cell growth for medical, veterinary and pharmaceutical purposes; cell culture media for medical use; nutritional agents for processing living cells, namely, cell culture media growth factors contained within a reservoir; synthetic peptides for the treatment of degenerated hard and soft tissues; synthetic peptide derivativesfor the treatment of degenerated hard and soft tissues; cells for medical, veterinary and pharmaceutical use; cells or tissues in hydrogels for medical, veterinary or pharmaceutical use; pharmaceutical preparations for use in 3D bio-printing of tissues and organs; pharmaceutical preparations with other materials and ingredients for use in 3D bio-printing of tissues and organs; regenerative tissue being pharmaceutical preparations for hard and soft tissue regeneration; cells for medical use; allogeneic human tissue; living cells for medical use; implants containing living tissue; implantable living tissue materials for use in guided tissue regeneration; skin grafts; surgical implants formed by living tissue; surgical implants of living tissues derived from stem cells; transdermal patches for the creation of skin for prostheses and skin grafts; living tissue for transplants; engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, epithelial, muscular, and nervous tissues and organs, for medical purposes; biological molecules being implants comprising living tissue to assist in tissue engineering, namely, hard and soft tissue regeneration; hemostatic gel matrix preparations for wound treatment; natural biomaterials for the growth of bones, blood and tissues for medical purposes; pharmaceutical products for the regeneration of tissues, for the repair of tissues, for the treatment of tissues, whether human or animal, namely, 3D implants for hard and soft tissue regeneration combining bioinks and biological materials; pharmaceutical preparations for the treatment of diseases of bones, cartilages, blood vessels, nerve cell degeneration, tendon and ligament degeneration, retinal degeneration, kidney degeneration; soft tissue degenerations, for diseases with abnormal cell growth, namely, formulated bioinks for hard and soft tissue regeneration combining bioinks and biological materials with a pharmaceutical effect; natural biomaterial for bone filling; natural biomaterial for cartilage filling; biological tissue cultures for medical use; biological tissue cultures for medical purposes; biological tissue grafts; bone and skin biological tissues impregnated with oxygen lines for tissue constructs applicable for increasing the cell survival in tissue intended for subsequent implants; gene therapy products, namely, genetically modified tissues for the transplant thereof; implantable stents composed primarily of living tissue to maintain the structure of the tissue; natural biomaterial for bone and tissue growth for medical purposes
Goods and ServicesInks of biological origin for printers; inks of biological origin for 3D printers
Goods and ServicesBiological materials or preparations for 3D printers, namely, bioinks, bioprinting kits comprised of collagen, biological printed tissues other than for medical or veterinary purposes; hydrogels for cell culture not for medical or veterinary purposes; hydrogels for cell growth not for medical or veterinary purposes; cell culture media other than for medical or veterinary use; nutritional agents for processing living cells other than for medical use, namely, cell culture media within a reservoir for growth factors; culture media for microbiology for laboratory use; reagents for scientific and medical research; synthetic peptides not for pharmaceutical purposes, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; synthetic peptide derivatives not for pharmaceutical purposes, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; cells other than for medical, veterinary or pharmaceutical use; cells or tissues in hydrogels other than for medical, veterinary or pharmaceutical use; biologically compatible polymers, specifically hydrogels used to produce polymer networks used in the manufacture of engineered living tissues for medical, scientific and non-scientific purposes, namely, tissue implants, organoids, tissue models; cell culture media for use in the biotechnological industry for laboratory use; cell culture media for use in non-medical research laboratories; biological preparations for use in cell culture, other than for medical and veterinary purposes; engineered living tissues and tissue arrays, namely, human and animal organs, connective tissue, epithelial tissue, muscular tissue and nervous tissue, and tissue arrays, for use in scientific and medical research; biologically compatible materials, specifically, hydrogels used to create polymeric networks used in the manufacture of living tissues for laboratory use; proteins in the form of raw materials for scientific and medical research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, October 21, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class002 - Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood; colorants; mordants; raw natural resins; metals in foil and powder form for painters, decorators, printers and artists.
US Class Codes006, 011, 016
Class Status Code6 - Active
Class Status DateFriday, October 21, 2022
Primary Code002
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVISCOFAN, S.A.
Party Type20 - Owner at Publication
Legal Entity Type88 - NOT AVAILABLE
AddressES

Party NameVISCOFAN, S.A.
Party Type10 - Original Applicant
Legal Entity Type88 - NOT AVAILABLE
AddressES

Trademark Events


Event DateEvent Description
Wednesday, March 1, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 20, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 25, 2022APPLICATION FILING RECEIPT MAILED
Thursday, February 23, 2023ASSIGNED TO EXAMINER
Tuesday, February 28, 2023NON-FINAL ACTION WRITTEN
Saturday, April 22, 2023REFUSAL PROCESSED BY MPU
Saturday, April 22, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 17, 2023REFUSAL PROCESSED BY IB
Friday, October 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 1, 2024NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, November 29, 2023FINAL REFUSAL WRITTEN
Wednesday, November 29, 2023FINAL REFUSAL E-MAILED
Wednesday, November 29, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, March 20, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, March 20, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, April 8, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, May 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 5, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 11, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, June 25, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 25, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 9, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED